Abstract

Background and Objectives: Thyroid hormones play one of the most vital roles in functioning of body including reproductive function. Thyroid dysfunctions are becoming more prevalent worldwide. Thyroid disorders are more common in women than men. Women after menopause are at enhanced risk of developing thyroid disorders. Aim of the study was to compare thyroid profile of postmenopausal women with those in reproductive age group. Methods: The present study consists of total 500 women out of whom 250 women were of reproductive age group aged between 15-49 years and 250 post menopausal women aged 50-75 years. Thyroid status was assessed by estimating the serum levels of T3, T4, TSH in both the groups. Results: Thyroid profile was compared between women of reproductive age group and postmenopausal women. Serum TSH levels were slightly high in postmenopausal women compared to reproductive women, whereas Serum levels of tri iodothyronine and thyroxine are slightly higher in reproductive age group compared to postmenopausal women. But both are statistically not significant (p-value >0.05). Conclusion: Thyroid screening may be advisable as routine investigation for all women at least once in 3-4 months for early detection of thyroid dysfunction.

• 1.   Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P,Schiettecatte J, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 2002;12:997–1001.
• 2.   Krassas GE, Pontikides N, Kaltsas T, Papadopoulou P, Batrinos M. Menstrual disturbances in thyrotoxicosis. Clin Endocrinol 1994;40:641–4.
• 3.   Tanaka T, Tamai H, Kuma K, Matsuzuka F, Hidaka H. Gonadotropin response to luteinizing hormone releasing hormone in hyperthyroid patients with menstrual disturbances. Metabolism 1981;30:323–6.
• 4.   Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702–55.
• 5.   Kakuno Y, Amino N, Kanoh M, Kawai M, Fujiwara M, Kimura M, et al.Menstrual disturbances in various thyroid diseases. Endocr J2010;57:1017–22.
• 6.   Sarne D: Effects of the environment, chemicals and drugs on thyroid function . Endotext [Internet]. De GrootLJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, RebarR, Singer F, Vinik A, Weickert MO (ed): MDText.com, Inc., South Dartmouth, MA; 2000. 2000:NBK285560
• 7.   Benhadi N, Fliers E, Visser TJ, Reitsma JB, Wiersinga WM: Pilot study on the assessment of the setpoint of the hypothalamus-pituitarythyroid axis in healthy volunteers. Eur J
• 8.   Brabant G, Prank K, Ranft U, et al.: Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab. 1990, 70:403-409.
• 9.   Surks MI, Hollowell JG: Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007,92:4575-4582.
• 10.   Rojas LV, Nieves K, Suarez E, Ortiz AP, Rivera A, Romaguera J: Thyroid-stimulating hormone and folliclestimulating hormone status in Hispanic women during the menopause transition. Ethn Dis. 2008, 18:230
• 11.   Pearce EN: Thyroid dysfunction in perimenopausal and postmenopausal women. Menopause Int. 2007, 13:8-13.
• 12.   Mariotti S, Barbesino G, Caturegli P, et al.: Complex alteration of thyroid function in healthy centenarians. JClin Endocrinol Metab. 1993, 77:1133-1134.
• 13.   Hershman JM, Pekary AE, Berg L, Solomon DH, Sawin CT: Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc. 1993, 41:823-828.
• 14.   Jacobson MH, Howards PP, Darrow LA, et al.: Thyroid hormones and menstrual cycle function in a longitudinal cohort of premenopausal women. Paediatr Perinat Epidemiol. 2018, 32:225-234.
• 15.   Topaloglu O, Gokay F, Kucukler K, et al.: Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status.Endocrine. 2013, 44:145-151.
• 16.   Santin AP, Furlanetto TW: Role of estrogen in thyroid function and growth regulation Thyroid Res. 2011,2011:875125.
• 17.   Xu S, Chen G, Peng W, Renko K, Derwahl M: Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules?. J Endocrinol. 2013, 218:125-133
• 18.   Mazer NA: Interaction of estrogen therapy and thyroid hormone replacement in postmenopausal women. Thyroid. 2004, 14:S27-34
• 19.   Hara S, Nagata K, Kumata K, et al.: Estradiol affects Epstein-Barr virus reactivationinduced thyrotropin receptor antibody and immunoglobulin production in Graves’ disease patients and healthy controls. Viral Immunol. 2018, 31:486-49.
• 20.   Hollowell J.G., et al., serum Tsh,T4 and thyroid antibodies in the united states population. national health and nutrition survey (NHANES III) J Clin Endocrinol Metab.2002; 87:489-99.

Data Sharing Statement

Funding